ABVC - Company ID 0001173313
The table below shows ABVC BIOPHARMA, INC.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $681.48K | $248.38K | $60.16K | $85.27K | $5.83M | $4.27M |
| Short-term investments | $64.35K | $64.74K | $79.31K | $75.80K | $108.15K | - |
| Receivables | - | $1.53K | $1.53K | $98.33K | $280.69K | - |
| Inventory | - | - | - | $25.98K | $25.98K | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $2.50M |
| $2.18M |
| $1.66M |
| $2.99M |
| $9.63M |
| $6.17M |
| Property, plant & equipment | $12.84M | $511.09K | $7.97M | $573.98K | $525.88K | $514.83K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $21.06M | $7.54M | $14.49M | $9.86M | $13.70M | $11.61M |
| Accounts payable | - | - | - | - | $23.04K | $23.04K |
| Total current liabilities | $6.16M | $6.56M | $5.93M | $5.82M | $3.69M | $4.84M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $7.76M | $6.82M | $6.36M | $6.62M | $4.83M | $8.94M |
| Retained earnings | -$76.86M | -$68.95M | -$65.42M | -$54.90M | -$38.48M | -$25.64M |
| Total equity | $11.11M | $1.23M | $8.39M | $3.10M | $8.84M | $3.44M |